Fig 1: Identification of CDS1/CDS2 synthetic lethality across multiple tumor types.a, Analysis of single-cell sequencing data from the uveal melanoma microenvironment reveals strong expression of CDS2 in malignant cells. b, CDS1 and CDS2 gene expression in cancers based upon data generated by the TCGA Research Network and obtained from the UCSC Xena platform61. Shown is the data range (mean − s.e. to the mean + s.e.) with points equaling the mean. c, Waterfall plot depicting CDS2 Chronos gene effect across 1013 pan-cancer cell lines from Project Achilles, DepMap 23Q4. Each column represents a cell line colored by CDS1 expression. d, Comparison of CDS2 essentiality in CDS1 low expressers (log2(TPM + 1) < 1) versus high expressers (log2(TPM + 1) ≥ 1) across 937 nonuveal melanoma cell lines analyzed in Broad DepMap (22Q2). A t test (two-sided, equal variance) was performed to compute significance. Box and whisker plots indicate the median and the 5th to 95th percentiles. Outliers as dots. e, Correlation between CDS1 methylation and expression. Methylation fraction represents a weighted average of the methylation ratios of all CpG sites within 1,000 bp from a gene’s transcriptional start site. The methylation ratio of each CpG site was determined by the number of reads where that CpG was methylated over the total number of reads covering that CpG. The weights of each CpG are calculated by the total number of reads covering that CpG overall and the total number of reads covering any CpG within 1,000 bp of the gene’s transcriptional start site. Data obtained from DepMap 23Q2 (ref. 69). Each dot represents a cell line. f, Genetic rescue of CDS2 lethality with a CDS1 cDNA. OMM2.5 cells were transduced with either an sgRNA targeting CDS2 or a control sgRNA (STG). As indicated, cells were also transduced with the CDS1 cDNA and cultured for 14 days before staining with crystal violet. The data shown is representative of three biological replicates performed in triplicate. Each circle is a well of a six-well plate.Source data
Fig 2: Top digenic and monogenic dependencies identified from combinatorial pgRNA CRISPR library analysis.a, Calculation of the GI score to quantify synthetic lethality. The sum of the observed log2(FC) for sgRNAs targeting gene A and gene B was calculated to determine the predicted log2(FC) of that gene pair. The difference between the predicted and experimentally observed log2(FC) was also calculated. b, Number of significantly depleted gene pairs across the cell lines screened. c, Dot plot depicting top synthetic lethal gene pairs from the combinatorial CRISPR screen that were common to at least 6 of the 10 screened cell lines, ranked (top to bottom) by descending mean GI score. Each dot represents the GI score of a given gene pair in a single cell line. All gene pairs had previously been screened across five independent CRISPR combinatorial screens and are colored by whether they were reported to be synthetic lethal in those studies19–23. Any pair where one of the genes was defined as lethal on its own was removed. d, Dot plot depicting significantly depleted single genes (genes with an STG) that were defined by Ensembl to have a paralog and common to at least six of the ten screened cell lines, ranked (top to bottom) by descending mean normalized log2(FC). log2(FCs) are normalized so that the median of the STGs was 0 and the median of the reference essential guides was −1. Genes are labeled with their paralog in parentheses. Each dot represents a cell line. Color indicates the synthetic lethality across five previous combinatorial CRISPR screens19–23. A nonhit (gray) denotes a gene not previously reported to have a synthetic lethal interaction with its partner. Significance was defined using an FDR < 0.05 (Methods). e, Correlation between INTS6L expression and INTS6 gene essentiality in 316 Project Score47 cell lines, and the same for CDS1/CDS2. Low expressers (log2(TPM + 1) < 1) versus high expressers (log2(TPM + 1) ≥ 1) were defined using expression profiles from Cell Model Passports. Significance was determined by a t test (two-sided, equal variance). Box and whisker plots indicate median and 5th to 95th percentiles; points are outliers.
Fig 3: Mechanistic insights into the effects of CDS2 loss.a, Clonogenic assay showing the effects of CDS2 disruption at day 14 following the addition of Dox to Cas9-expressing cells that contain a Dox-inducible CDS2 or an STG control sgRNA (STG2). Data were collected from three independent biological replicates for each cell line (triangles, OMM2.5; circles, MP41). Representative plates are shown for one replicate of the OMM2.5 cell line. P values were calculated with Welsh’s two-tailed t test (without correction). Circles are a well of a six-well plate. b, Flow cytometry results from apoptosis assays at day 14 following CDS2 sgRNA induction with Dox, compared with induction of an STG sgRNA control. Data collected from three biological replicates. Data shown are mean and s.d. P values were calculated using a two-tailed t test. Wild-type cells are shown for comparison. c, Disruption of CDS2 following Dox treatment leads to a progressive reduction in the phosphoinositides PI and PIP and an increase in the precursor PA, compared with the DMSO control. Data are represented as mean ± s.e.m. from three independent MP41 clones and one OMM2.5 clone across three independent experiments. P values were calculated using a two-way ANOVA with Sidak’s correction with significant values shown. d, 4,4-Difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene (BODIPY 493/503) staining (green) of lipid droplets in cells treated with Dox or DMSO for 14 days. DAPI-stained nuclei (blue). This experiment was performed twice independently. e, Schematic of the in vivo experiments performed in 28 female mice at 8 weeks of age (NOD-Prkdcscid-IL2rgTm1/Rj background). After implantation of tumor cells, mice were blindly randomized into two groups (Methods) with the switch to a Dox-containing diet occurring on day 24 (arrow). Data shown are mean ± s.d. Significance was determined using a mixed-effects model with the Geisser–Greenhouse correction. f, Schematic of the role of CDS1/CDS2 in phosphoinositide de novo synthesis and recycling.Source data
Supplier Page from OriGene Technologies for CDS1 (NM_001263) Human Tagged Lenti ORF Clone